GGrantIndex
Sort

25,944 grants matching neurodegeneration

Combine computational prediction, network analysis and genetic screening in C elegans to uncover neurodegenerative causes in Alzheimer's Disease

$635,171
Rong Xu · Case Western Reserve University · R01 · FY2018 · AG

Nitroxides as Protectors Against Oxidative Stress

$635,139
James B Mitchell · Clinical Sciences · Z01 · FY2007 · CA

Mechanism of Pathologic Tau Fibrils Neuron-to-Neuron Transmission and Neuroinflammation in Alzheimer's Disease

$634,859
Xiaobo Mao · Johns Hopkins University · R01 · FY2021 · AG

Mechanisms of Prion Protein Toxicity

$634,826
David A Harris · Boston University Medical Campus · R01 · FY2020 · NS

Training in the Neuroplasticity of Aging

$634,601
Edward H. Koo · University Of California, San Diego · T32 · FY2014 · AG

Project I: Alpha Synucleinopathy in the Human Brain Connectome

$634,597
David John Irwin · University Of Pennsylvania · P01 · FY2024 · AG

SCHIZOPHRENIA--PSYCHOPATHOLOGY AND HETEROGENEITY

$634,458
Harvard University (Medical School) · R01 · FY2002 · MH

Investigating Dysregulation of Stress-related Ribonucleoprotein Granules and Functions of Associated RNA-binding Proteins in ALS/FTD

$634,358
Jiou Wang · Johns Hopkins University · R01 · FY2024 · NS

Comparative transcriptome of brain blood vessels: age, hypertension and diabetes

$634,301
Eng H. Lo · Massachusetts General Hospital · RC2 · FY2010 · NS

Lentiviral Vectors for Gene Transfer

$634,206
Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2007 · HL

Morphologic/Neurochemical Correlates of Depression in AD

$634,131
George S Zubenko · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · MH

Neuroprotective role of GLP-1 receptor agonists

$634,082
Nigel H. Greig · National Institute On Aging · ZIA · FY2012 · AG

Morphologic/Neurochemical Correlates of Depression in AD

$634,059
George S Zubenko · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · MH

Complement activation in glaucoma

$634,045
John Danias · Suny Downstate Medical Center · R01 · FY2010 · EY

Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP

$633,691
Peter Alexander Ljubenkov · University Of California, San Francisco · R01 · FY2024 · AG

ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration

$633,662
Iris Lindberg · University Of Maryland Baltimore · R01 · FY2021 · AG

ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration

$633,662
Iris Lindberg · University Of Maryland Baltimore · R01 · FY2022 · AG

ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration

$633,662
Iris Lindberg · University Of Maryland Baltimore · R01 · FY2020 · AG

ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration

$633,662
Iris Lindberg · University Of Maryland Baltimore · R01 · FY2023 · AG

Role of PERK haplotypes in HIV-Associated Neurocognitive Disorders

$633,621
Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2016 · MH

Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE

$633,458
Beate R Ritz · University Of California Los Angeles · R01 · FY2022 · ES

Role of the Innate Immune System in the Survival of Auditory Neurons

$633,415
Mark E. Warchol · Washington University · R01 · FY2017 · DC

Brain and Behavioral Indicators of Risk for Parkinsonism among Adolescents with Early Pesticide Exposure

$633,281
Virginia A Rauh · Columbia University Health Sciences · R01 · FY2019 · ES

Regulation of autophagy during animal development

$633,205
Eric H Baehrecke · Univ Of Massachusetts Med Sch Worcester · R35 · FY2021 · GM

Regulation of autophagy during animal development

$633,205
Eric H Baehrecke · Univ Of Massachusetts Med Sch Worcester · R35 · FY2023 · GM